To examine a possible relation between the expression levels of HER1 and HER2 and the impact of PAbs on cell viability, a total of five tumor lines with differential expression of both receptors were incubated with PAbs during 96 hours and viability was tested as described. The gene discussed is EGFR; the disease is neoplasm.